Suppr超能文献

泰国流行地区丙型肝炎病毒的流行情况:消除丙型肝炎病毒负担评估。

Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination.

机构信息

1Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

2National Biobank of Thailand, National Science and Technology Development Agency, Pathum Thani, Thailand.

出版信息

Am J Trop Med Hyg. 2020 Jul;103(1):175-182. doi: 10.4269/ajtmh.19-0817. Epub 2020 May 7.

Abstract

Chronic hepatitis C virus (HCV) infection can lead to liver cirrhosis and hepatocellular carcinoma. To eliminate HCV infection in an endemic area, an epidemiological baseline of the current HCV infection in the population is required. We therefore aimed to evaluate the HCV burden in the Thai Province of Phetchabun, which has the highest HCV infection rate in the country. Toward this, a province-wide district-based representative sampling of 4,769 individuals ages 35-64 years previously shown to represent high-risk age-groups were tested for anti-HCV antibodies using the automated chemiluminescent microparticle assays. Active HCV infection and subsequent genotyping were determined from serologically reactive samples by amplification of the HCV core gene. We found that 6.9% (327/4,769) were anti-HCV positive, of which 75.8% (248/327) had detectable HCV RNA and 5.8% (19/327) were in the presence of hepatitis B virus coinfection. Nucleotide sequencing and phylogenetic analysis revealed that HCV genotype 6 was the most prevalent (41%, 101/248), followed by genotype 3 (31%, 78/248), and genotype 1 (28%, 69/248). Socioeconomic and demographic factors including male gender, education, and agricultural work were associated with HCV seropositivity. From these results, we defined the regional HCV genotypes and estimated the HCV burden necessary toward the implementation of pan-genotypic direct-acting antivirals, which may be appropriate and effective toward the diversity of genotypes identified in this study. Micro-elimination of HCV in Phetchabun may serve as a model for a more comprehensive coverage of HCV treatment in Thailand.

摘要

慢性丙型肝炎病毒(HCV)感染可导致肝硬化和肝细胞癌。为了在流行地区消除 HCV 感染,需要对当前人群中 HCV 感染的流行情况进行流行病学基线调查。因此,我们旨在评估泰国碧差汶府的 HCV 负担,该府的 HCV 感染率是全国最高的。为此,我们对该省 35-64 岁的 4769 名具有代表性的人群进行了基于区县级的抽样检测,采用自动化化学发光微粒子免疫分析检测抗 HCV 抗体。从血清学反应性样本中通过 HCV 核心基因扩增确定活性 HCV 感染和随后的基因分型。我们发现,6.9%(327/4769)的人抗 HCV 阳性,其中 75.8%(248/327)的人 HCV RNA 可检测到,5.8%(19/327)的人同时感染乙型肝炎病毒。核苷酸测序和系统发育分析显示,HCV 基因型 6 最为流行(41%,101/248),其次是基因型 3(31%,78/248)和基因型 1(28%,69/248)。包括性别、教育程度和农业工作在内的社会经济和人口统计学因素与 HCV 血清阳性相关。根据这些结果,我们确定了该地区的 HCV 基因型,并估计了实施泛基因型直接作用抗病毒药物所需的 HCV 负担,这可能对本研究中鉴定的多种基因型是合适和有效的。在碧差汶府消灭 HCV 可能成为泰国更全面 HCV 治疗覆盖的典范。

相似文献

1
Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination.
Am J Trop Med Hyg. 2020 Jul;103(1):175-182. doi: 10.4269/ajtmh.19-0817. Epub 2020 May 7.
4
Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.
PLoS One. 2015 May 11;10(5):e0126764. doi: 10.1371/journal.pone.0126764. eCollection 2015.
5
Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
PLoS One. 2017 May 5;12(5):e0177022. doi: 10.1371/journal.pone.0177022. eCollection 2017.
6
Genotyping of hepatitis B and C virus Russian isolates for reference serum panel construction.
J Med Virol. 2015 Jul;87(7):1192-8. doi: 10.1002/jmv.24170. Epub 2015 Mar 10.
7
Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
PLoS One. 2016 Feb 12;11(2):e0149362. doi: 10.1371/journal.pone.0149362. eCollection 2016.
8
Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile.
Virol J. 2017 Nov 2;14(1):208. doi: 10.1186/s12985-017-0873-7.
9
Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
World J Gastroenterol. 2016 Nov 14;22(42):9427-9436. doi: 10.3748/wjg.v22.i42.9427.

引用本文的文献

4
Hepatitis B prevalence in an endemic area of hepatitis C virus: A population-based study implicated in hepatitis elimination in Thailand.
J Virus Erad. 2024 Dec 11;10(4):100577. doi: 10.1016/j.jve.2024.100577. eCollection 2024 Dec.
6
Population and transmission dynamics model to determine WHO targets for eliminating Hepatitis C virus in Thailand.
PLoS One. 2024 Oct 16;19(10):e0309313. doi: 10.1371/journal.pone.0309313. eCollection 2024.
7
Historical drivers of HCV Subtypes 1b and 3a in Thailand and 6f in Phetchabun, an HCV endemic area of the country.
Virus Evol. 2024 Sep 11;10(1):veae079. doi: 10.1093/ve/veae079. eCollection 2024.
8
Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.
PLoS One. 2024 May 13;19(5):e0303265. doi: 10.1371/journal.pone.0303265. eCollection 2024.
9
An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA.
PLoS One. 2023 Jun 29;18(6):e0287694. doi: 10.1371/journal.pone.0287694. eCollection 2023.
10
Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study.
Open Access Rheumatol. 2023 May 16;15:81-92. doi: 10.2147/OARRR.S410165. eCollection 2023.

本文引用的文献

1
A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination.
Am J Trop Med Hyg. 2019 Nov;101(5):963-972. doi: 10.4269/ajtmh.19-0295.
3
Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience.
J Clin Exp Hepatol. 2019 May-Jun;9(3):283-293. doi: 10.1016/j.jceh.2018.12.001. Epub 2018 Dec 19.
4
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018.
MMWR Morb Mortal Wkly Rep. 2019 Jul 26;68(29):637-641. doi: 10.15585/mmwr.mm6829a2.
5
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.
J Hepatol. 2019 Dec;71(6):1076-1085. doi: 10.1016/j.jhep.2019.07.006. Epub 2019 Jul 17.
6
Global Elimination of Chronic Hepatitis.
N Engl J Med. 2019 May 23;380(21):2041-2050. doi: 10.1056/NEJMra1810477.
8
Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017.
Sci Rep. 2019 May 13;9(1):7314. doi: 10.1038/s41598-019-43785-4.
9
Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.
PLoS One. 2018 Aug 23;13(8):e0202991. doi: 10.1371/journal.pone.0202991. eCollection 2018.
10
An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Lancet Gastroenterol Hepatol. 2018 Nov;3(11):778-789. doi: 10.1016/S2468-1253(18)30139-0. Epub 2018 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验